Mesahenz 1200mg Tablet

  • Manufacturer : La Renon Healthcare Pvt. Ltd.
  • Composition : Mesalazine/Mesalamine 1200mg
  • Generally Prescribed For : Inflammatory Bowel Disease, Including Ulcerative Colitis, Inflamed Anus or Rectum, Maintain Remission in Crohn's Disease
  • Estimated Price : 190.00 For 10 Tablets Strip

BUY FROM THESE SELLERS

Uses of Mesahenz 1200mg Tablet

Mesahenz 1200mg Tablet is used for the treatment or prevention of the following disease(s):

Inflammatory Bowel Disease, Including Ulcerative Colitis, Inflamed Anus or Rectum, Maintain Remission in Crohn's Disease

Side effects of Mesahenz 1200mg Tablet

The most common side effects of Mesahenz 1200mg Tablet are - Fever, Sore Throat or Other Flu Symptoms, Constipation, Headache or Dizziness, Mild Nausea, Vomiting, Stomach Cramps, Diarrhea, Gas, Tired Feeling, Skin Rash

These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.

Precautions while using Mesahenz 1200mg Tablet

Do not use Mesahenz 1200mg Tablet if you are allergic to - Mesalazine/Mesalamine

If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Mesahenz 1200mg Tablet.

If you are allergic to any medicine or food, consult your doctor before using this medicine.

Use this medicine under the supervision of your doctor.

To avoid an adverse reaction, consult your doctor if you are already taking other medicines.

How Mesahenz 1200mg Tablet works

Mesahenz 1200mg Tablet contains - Mesalazine/Mesalamine

Mesalazine acts locally on colonic mucosa and reduces inflammation through a variety of anti-inflammatory processes.

Dosage of Mesahenz 1200mg Tablet

The dosage of Mesahenz 1200mg Tablet depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.

Please use this medicine as prescribed by your doctor.

Overdose of Mesahenz 1200mg Tablet

If you forget to take a dose of Mesahenz 1200mg Tablet, do not take two doses at the same time, there is a risk of overdose.

If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.

Precautions & Warnings

  • ...
  • Alcohol Information will be added soon.

  • ...
  • Pregnancy Information will be added soon.

  • ...
  • Breastfeeding Information will be added soon.

  • ...
  • Driving Information will be added soon.

  • ...
  • Kidney Information will be added soon.

  • ...
  • Liver Information will be added soon.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.

Vegaz OD 1200mg Tablet PR
Dr. Reddy's Laboratories Ltd.
308.00
10 Tablets Strip Tablets Strip
Cosala OD 1200mg Tablet
Tas Med India Pvt. Ltd.
240.00
10 Tablets Strip Tablets Strip
View all alternate brands

Interaction

Information will be added soon.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

About Author

  • Dr. Naresh Dang, MD
  • Dr. Naresh Dang, MD Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience i...
    ...

    Dr. Naresh Dang, MD Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience in his chosen field of specialty. Dr. Dang is an expert in the managememnt of Diabetes, Hypertension and Lipids. He also provides consultation for Life Style Management.
    ...

About Author

  • Sonu Kumar, D.Pharma
  • Sonu Kumar, D.Pharma Sonu Kumar is a registered pharmacist with Bihar State Pharmacy Council with over 6 months experience. He is a medicine content contributor at Zotezo....

    Sonu Kumar, D.Pharma Sonu Kumar is a registered pharmacist with Bihar State Pharmacy Council with over 6 months experience. He is a medicine content contributor at Zotezo.

ZOTEZO IN THE NEWS

...